Tumor microenvironment-associated oxidative stress impairs SIRT1 secretion to suppress anti-tumor immune response

Zhuo Wang1, Wendong Guo1, Xiaowen Zhang1

  • 1Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, Liaoning 110122, China; Health Sciences Institute, China Medical University, Shenyang, Liaoning 110122, China.

Cell Reports
|May 9, 2025
PubMed

Insights

Sirtuin-1 (SIRT1) normally inhibits tumor growth but becomes methylated in the tumor microenvironment (TME). This prevents M2 macrophages from acquiring SIRT1, increasing PD-L1 and causing T cell exhaustion, revealing a novel immune evasion mechanism.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cancer Research

Background:

  • Sirtuin-1 (SIRT1) is a histone deacetylase involved in cellular processes like metabolism and DNA repair.
  • SIRT1's role in the tumor microenvironment (TME) and its secretion pathways are not fully understood.

Purpose of the Study:

  • To investigate the secretion of SIRT1 into the TME.
  • To elucidate the impact of TME stress on SIRT1 secretion and its downstream effects on tumor immunity.

Main Methods:

  • Analysis of unconventional protein secretion pathways.
  • Assessment of SIRT1 methylation under TME stress.
  • Evaluation of SIRT1 levels in M2 macrophages.
  • Measurement of PD-L1 expression and CD8+ T cell exhaustion.

Main Results:

  • SIRT1 is secreted into the TME via an unconventional pathway, inhibiting tumor growth.
  • TME stress increases SIRT1 methylation, hindering its secretion.
  • Reduced SIRT1 in M2 macrophages leads to increased PD-L1 expression.
  • Elevated PD-L1 on M2 macrophages promotes CD8+ T cell exhaustion.

Conclusions:

  • SIRT1 secretion and its regulation by methylation are critical in the TME.
  • Impaired SIRT1 acquisition by M2 macrophages contributes to tumor immune evasion.
  • These findings offer new insights into targeting SIRT1 for cancer immunotherapy.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K